Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LogicBio Therapeutics Inc
LOGC | US
9.04
USD-0.01
-0.11%
LOGC | US
About LogicBio Therapeutics Inc
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
9.04
Open
9.05
High
9.15
Low
8.92
View Less
LOGC | US
Risk
20.6
Sharpe
0.17
Luna's Score
48/100
Recommendation
Hold
Luna says (LOGC | US)
What's Working
Positive Momentum
Low 6-Month Volatility (<30%)
Value Stock (Price to Book < 3)
What's not Working
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
24.8%1 month
20.6%3 months
25.4%6 months
23.7%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
1.02
Debt to equity
-
Debt to assets
-
Ent. to EBITDA
0.99
Ent. to rev.
0.05
PEG
-
Other Fundamentals
EBITDA
-207.00M
MarketCap
237.52M
MarketCap(USD)
237.52M
Div. yield
-
Op. margin
-271.43
Erngs. growth
-
Rev. growth
-91.00
Ret. on equity
-89.61
Short ratio
11.89
Short perc.
10.30
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
0.90
Range1M
0.90
Range3M
1.40
Volumes: Market Activity
Rel. volume
0.40
Price X volume
379.35K
